THERAKOSTM CELLEXTM

PHOTOPHERESIS SYSTEM

TAKE A MOMENT TO EXPLORE THE

ADVANCED FUNCTIONALITIES

Designed for Excellence in ECP

The THERAKOS™ CELLEX™ Photopheresis System is
the world’s only fully integrated and validated ECP
system1.

EFFICIENCY & REASSURANCE

CELLEXTM System average treatment

time1

Single-needle mode: 103.0 mins

Double-needle mode: 74.4 mins

Reassurance for physicians and

operators, comfort for the patient

Flexibility of switching between single- or

double-needle modes at any time during the
procedure

Enables adapting to the patients’ venous

access conditions1

Peristaltic pumps provide smooth vein

pressure4

Gives confidence to you and comfort to your

patients
Because your patient remains connected
throughout the procedure:

Minimised re-infusion errors and cross-

contamination2,3

Minimal risk of microbial contamination2,3

1. Bisaccia E, et al. Br J Dermatol. 2009;161(1):167-169. 2. Knobler R, et al.

J Eur Acad Dermatol Venereol. 2014;28 Suppl 1:1-37. 3. Perotti C,
Sniecinski I. Transfus Apher Sci. 2015;52(3):360-368. 4. Therakos, Inc.
Operator’s Manual. THERAKOS™ CELLEX™ Photopheresis System.
Available at: https://www.mallinckrodt.ca/wp-
content/uploads/2018/08/Operators-Manual.pdf. Accessed October
2019.

VERSATILITY

AUTOMATION FOR SIMPLICITY

ADJUSTING TO THE PATIENT

UNIQUE CHARACTERISTICS

VALIDATED PERFORMANCE FOR ECP

FULLY INTEGRATED & VALIDATED

MY AREA

GET TO KNOW THE ECP

PROCEDURE WITH THE CELLEXTM
SYSTEM

The procedural steps

The instrument collects a small fraction of blood
1 from the patient

2 The blood is separated by centrifugation

Red blood cells and plasma are returned

3 immediately to the patient

Methoxsalen* is added to the buffy coat fraction†

4 and cells are photoactivated by ultraviolet A light

The photoactivated buffy coat fraction† is

5 reinfused to the patient

Please refer to the appropriate operator’s manual for

further details prior to prescribing ECP therapy.
*
Exact mechanism of action (MoA) of methoxsalen is
unknown.
†
The buffy coat fraction of a whole blood sample
following centrifugation contains most of the white
blood cells and platelets.

Already have the

TM
CELLEX System?
Get the most out of your device and visit our
new Therakos e-learning platform

THERAKOS ECP
IMMUNOMODULATIONTM

DISCOVER MORE

This website is not intended for healthcare professionals

based in US, France and Canada.

CELLEXTM device registrations vary globally. Please refer

to your local country label for more information. For
further support please contact your local company
representative.

PRESS RELEASES | CAREERS | CONTACT US

Privacy Policy | Terms and Conditions | Important

Safety Information